Changes in the hemagglutinin molecule of influenza type A (H3N2) virus associated with increased virulence for mice

Archives of Virology

Volumn 142, Issue 1, 1997, Pages 75-88

  Hartley, C A ^a   Reading, P C ^a   Ward, A C ^a,b   Anders, E M ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b CSIRO   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VIRUS HEMAGGLUTININ;

ANIMAL; ARTICLE; C57BL MOUSE; CATTLE; FEMALE; GENETICS; INFLUENZA VIRUS A; INFLUENZA VIRUS A H3N2; MALE; MOLECULAR GENETICS; MOUSE; MUTATION; NUCLEOTIDE SEQUENCE; PATHOGENICITY; VIRULENCE;

ANIMALS; CATTLE; FEMALE; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; INFLUENZA A VIRUS; INFLUENZA A VIRUS, H3N2 SUBTYPE; MALE; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; MUTATION; VIRULENCE;

ANIMALIA; BOS TAURUS; BOVINAE; INFLUENZA VIRUS; INFLUENZAVIRUS A; MURINAE;

EID: 0031014661     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007050050060     Document Type: Article

References (39)

1. Anders EM, Hartley CA, Jackson DC (1990) Bovine and mouse serum β inhibitors of influenza A viruses are mannose-binding lectins. Proc Natl Acad Sci USA 87: 4485-4489
2. Anders EM, Hartley CA, Reading PC, Ezekowitz RAB (1994) Complement-dependent neutralization of influenza virus by a serum mannose-binding lectin. J Gen Virol 75: 615-622
3. Benne CA, Kraaijeveld CA, van Strijp JAG, Brouwer E, Harmsen M, Verhoef J, van Golde LMG, van Iwaarden JF (1995) Interactions of surfactant protein A with influenza viruses: binding and neutralization. J Infect Dis 171: 335-341
4. Brans LM, Hertzberger E, Binkhorst JL (1953) Studies on the elimination of nonspecific inhibitor in sera against influenza viruses with the aid of filtrates of Vibrio cholerae. Antonie V Leeuwenhoek 19: 309-323
5. Briody BA, Cassel WA, Medill MA (1955) Adaptation of influenza virus to mice. III. Development of resistance to β inhibitor. J Immunol 74: 41-45
6. Brown EG (1990) Increased virulence of a mouse-adapted variant of influenza A/FM/1/47 virus is controlled by mutations in genome segments 4, 5, 7 and 8. J Virol 64: 4523-4533
7. Brown LE, Murray JM, White DO, Jackson DC (1990) An analysis of monoclonal antibodies directed to epitopes on influenza virus hemagglutinin. Arch Virol 114: 1-26
8. Bullough PA, Hughson FM, Skehel JJ, Wiley DC (1994) Structure of influenza haemagglutinin at the pH of membrane fusion. Nature 371: 37-43
9. Chu CM (1951) The action of normal mouse serum on influenza virus. J Gen Microbiol 5: 739-757
10. Daniels RS, Downie JC, Hay AJ, Knossow M, Skehel JJ, Wang ML, Wiley DC (1985) Fusion mutants of the influenza virus hemagglutinin glycoprotein. Cell 40: 431-439
11. Daniels RS, Jeffries S, Yates P, Schild GC, Rogers GN, Paulson JC, Wharton SA, Douglas AR, Skehel JJ, Wiley DC (1987) The receptor-binding and membrane-fusion properties of influenza virus variants selected using anti-haemagglutinin monoclonal antibodies. EMBO J 6: 1459-1465
12. Doms RW, Gething M-J, Henneberry J, White J, Helenius A (1986) Variant influenza virus hemagglutinin that induces fusion at elevated pH. J Virol 57: 603-613
13. Gitelman AK, Kaverin NV, Kharitonenkov IG, Rudneva IA, Zhdanov VM (1984) Changes in the antigenic specificity of influenza virus haemagglutinin in the course of adaptation to mice. Virology 134: 230-232
14. Hartley CA, Jackson DC, Anders EM (1992) Two distinct serum mannose-binding lectins function as ßinhibitors of influenza virus: identification of bovine serum ß inhibitor as conglutinin. J Virol 66: 4358-4363
15. Hartshorn KL, Crouch EC, White MR, Eggleton P, Tauber AI, Chang D, Sastry K (1994) Evidence for a protective role of pulmonary surfactant protein D (SP-D) against influenza A viruses. J Clin Invest 94: 311-319
16. Hartshorn KL, Sastry K, Brown D, White MR, Okarma TB, Lee Y-M, Tauber AI (1993) Conglutinin acts as an opsonin for influenza A viruses. J Immunol 151: 6265-6273
17. Hartshorn KL, Sastry K, White MR, Anders EM, Super M, Ezekowitz RAB, Tauber AI (1993) Human mannose-binding protein functions as an opsonin for influenza Aviruses. J Clin Invest 91: 1414-1420
18. Hirst GK (1947) Studies on the mechanism of adaptation of influenza virus to mice. J Exp Med 86: 357-366
19. Holmskov U, Malhotra R, Sim RB, Jensenius J (1994) Collectins: collagenous C-type lectins of the innate immune defense system. Immunol Today 15: 67-74
20. Katz JM, Wang M, Webster RG (1990) Direct sequencing of the HA gene of influenza (H3N2) virus in original clinical samples reveals sequence identity with mammalian cell-grown virus. J Virol 64: 1808-1811
21. Kaverin NV, Finskaya NN, Rudneva IA, Gitelman AK, Kharitonenkov IG, Smirnov YA (1989) Studies on the genetic basis of human influenza A virus adaptation to mice: degrees of virulence of reassortants with defined genetic content. Arch Virol 105: 29-37
22. Kawaoka Y, Naeve CW, Webster RG (1984) Is virulence of H5N2 influenza viruses in chickens associated with loss of carbohydrate from the hemagglutinin? Virology 139: 303-316
23. Kilbourne ED, Schulman JL, Schild GC, Schloer G, Swanson J, Bucher D (1971) Correlated studies of a recombinant influenza virus vaccine. I. Derivation and characterization of virus and vaccine. J Infect Dis 124: 449-462
24. Laemmli UK (1970) Cleavage of the structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685
25. Marsh M, Helenius A (1989) Virus entry into animal cells. Adv Virus Res 36: 107-151
26. Nakajima S, Takeuchi Y, Nakajima K (1988) Location on the evolutionary tree of influenza H3 haemagglutinin genes of Japanese strains isolated during 1985-1986 season. Epidemiol Infect 100: 301-310
27. Newton SE, Air GM, Webster RG, Laver WG (1983) Sequence of the haemagglutinin gene of influenza virus A/Memphis/1/71 and previously uncharacterized monoclonal antibody-derived variants. Virology 128: 495-501
28. Ohuchi M, Orlich M, Ohuchi R, Simpson BEJ, Garten W, Klenk H-D, Rott R (1989) Mutations at the cleavage site of the hemagglutinin alter the pathogenicity of influenza virus A/Chick/Penn/83 (H5N2). Virology 168: 274-280
29. Raut S, Hurd J, Cureton RJ, Blandford G, Heath RB (1975) The pathogenesis of infections of the mouse caused by virulent and avirulent variants of an influenza virus. J Med Microbiol 8: 127-136
30. Reading PC, Hartley CA, Ezekowitz RAB, Anders EM (1995) A serum mannose-binding lectin mediates complement-dependent lysis of influenza virus-infected cells. Biochem Biophys Res Commun 217: 1128-1136
31. Rott R, Orlich M, Klenk H-D, Wang ML, Skehel JJ, Wiley DC (1984) Studies on the adaptation of influenza viruses to MDCK cells. EMBO J 3: 3329-3332
32. Sanger F, Nicklen S, Coulson AR (1977) DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74: 5463-5467
33. Sastry K, Ezekowitz RAB (1993) Collectins: pattern recognition molecules involved in first line host defense. Curr Opin Immunol 5: 59-66
34. Schulman JL (1983) Virus-determined differences in the pathogenesis of influenza virus infections. In: Palese P, Kingsbury DW (eds) Genetics of influenza viruses. Springer, New York, pp 305-320
35. Smeenk CA, Brown EG (1994) The influenza virus variant A FM/1/47-MA possesses single amino acid replacements in the hemagglutinin, controlling virulence, and in the matrix protein, controlling virulence as well as growth. J Virol 68: 530-534
36. Sweet C, Smith H (1980) Pathogenicity of influenza virus. Microbiol Rev 44: 303-330
37. Ward AC (1995) Specific changes in the M1 protein during adaptation of influenza virus to mice. Arch Virol 140: 383-389
38. Ward AC, de Koning-Ward TF (1995) Changes in the hemagglutinin gene of the neurovirulent strain A/NWS/33. Virus Genes 10: 179-183
39. Wiley DC, Skehel JJ (1987) The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. Annu Rev Biochem 56: 365-394